ArticlePDF Available

Abstract and Figures

Peripheral sensitization during inflammatory pain is mediated by a variety of endogenous proalgesic mediators including a number of oxidized lipids, some of which serve endogenous modulators of sensory TRP-channels. These lipids are eicosanoids of the arachidonic acid and linoleic acid pathway, as well as lysophophatidic acids (LPAs). However, their regulation pattern during inflammatory pain and their contribution to peripheral sensitization is still unclear. Here, we used the UVB-model for inflammatory pain to investigate alterations of lipid concentrations at the site of inflammation, the dorsal root ganglia (DRGs) as well as the spinal dorsal horn and quantified 21 lipid species from five different lipid families at the peak of inflammation 48 hours post irradiation. We found that known proinflammatory lipids as well as lipids with unknown roles in inflammatory pain to be strongly increased in the skin, whereas surprisingly little changes of lipid levels were seen in DRGs or the dorsal horn. Importantly, although there are profound differences between the number of cytochrome (CYP) genes between mice and rats, CYP-derived lipids were regulated similarly in both species. Since TRPV1 agonists such as LPA 18∶1, 9- and 13-HODE, 5- and 12-HETE were elevated in the skin, they may contribute to thermal hyperalgesia and mechanical allodynia during UVB-induced inflammatory pain. These results may explain why some studies show relatively weak analgesic effects of cyclooxygenase inhibitors in UVB-induced skin inflammation, as they do not inhibit synthesis of other proalgesic lipids such as LPA 18∶1, 9-and 13-HODE and HETEs.
Content may be subject to copyright.
Synthesis of Lipid Mediators during UVB-Induced
Inflammatory Hyperalgesia in Rats and Mice
Marco Sisignano
1
, Carlo Angioni
1
, Nerea Ferreiros
1
, Claus-Dieter Schuh
1
, Jing Suo
1
, Yannick Schreiber
1
,
John M. Dawes
2
, Ana Antunes-Martins
3
, David L. H. Bennett
2
, Stephen B. McMahon
3
, Gerd Geisslinger
1
,
Klaus Scholich
1
*
1Institute of Clinical Pharmacology, pharmazentrum Frankfurt/ZAFES, University Hospital of the Goethe-University, Frankfurt am Main, Germany, 2Nuffield Department of
Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom, 3Wolfson CARD, King’s College London, Guy’s Campus, London, United
Kindgom
Abstract
Peripheral sensitization during inflammatory pain is mediated by a variety of endogenous proalgesic mediators including a
number of oxidized lipids, some of which serve endogenous modulators of sensory TRP-channels. These lipids are
eicosanoids of the arachidonic acid and linoleic acid pathway, as well as lysophophatidic acids (LPAs). However, their
regulation pattern during inflammatory pain and their contribution to peripheral sensitization is still unclear. Here, we used
the UVB-model for inflammatory pain to investigate alterations of lipid concentrations at the site of inflammation, the dorsal
root ganglia (DRGs) as well as the spinal dorsal horn and quantified 21 lipid species from five different lipid families at the
peak of inflammation 48 hours post irradiation. We found that known proinflammatory lipids as well as lipids with unknown
roles in inflammatory pain to be strongly increased in the skin, whereas surprisingly little changes of lipid levels were seen in
DRGs or the dorsal horn. Importantly, although there are profound differences between the number of cytochrome (CYP)
genes between mice and rats, CYP-derived lipids were regulated similarly in both species. Since TRPV1 agonists such as LPA
18:1, 9- and 13-HODE, 5- and 12-HETE were elevated in the skin, they may contribute to thermal hyperalgesia and
mechanical allodynia during UVB-induced inflammatory pain. These results may explain why some studies show relatively
weak analgesic effects of cyclooxygenase inhibitors in UVB-induced skin inflammation, as they do not inhibit synthesis of
other proalgesic lipids such as LPA 18:1, 9-and 13-HODE and HETEs.
Citation: Sisignano M, Angioni C, Ferreiros N, Schuh C-D, Suo J, et al. (2013) Synthesis of Lipid Mediators during UVB-Induced Inflammatory Hyperalgesia in Rats
and Mice. PLoS ONE 8(12): e81228. doi:10.1371/journal.pone.0081228
Editor: Andrej A. Romanovsky, St. Joseph’s Hospital and Medical Center, United States of America
Received September 16, 2013; Accepted October 9, 2013; Published December 9, 2013
Copyright: ß2013 Sisignano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the DFG (German Research Association) grants SCHO817 and SFB1039 TPA08 and 09 and is part of the Europain
Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, resources of which are
composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution,
www.imi.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Marco.Sisignano@med.uni-frankfurt.de
Introduction
Inflammatory hyperalgesia is mediated through sensory changes
in the inflamed tissue. These include mechanisms of peripheral
sensitization of sensory neurons via release of proalgesic mediators
by immune cells at the site of inflammation. Proalgesic compo-
nents comprise of cytokines, growth factors such as the nerve
growth factor NGF, reactive molecules such as nitric oxide (NO)
and reactive oxygen species (ROS) as well as oxidized lipids [1,2].
Most of these substances specifically bind to receptors at the cell
membrane of sensory neurons which activate signaling cascades,
leading to the activation of protein kinases PKA and PKC [3,4].
The activated protein kinases then phosphorylate ligand gated ion
channels, such as the transient receptor potential (TRP)-channels
or sodium channels, thereby reducing their activation threshold
[5,6].
Apart from already known components that contribute to
inflammatory hyperalgesia, many oxidized lipids have recently
been identified to either directly activate or sensitize nociceptors
by either interacting with transducer ion channels of the transient
receptor potential (TRP)-family or sodium channels, or by
recruiting immune cells to the site of inflammation. Among these
lipids, eicosanoids, oxidized linoleic acid metabolites (OLAMs) and
lysophophatidic acids (LPA) can be found. LPAs can be generated
by the secretory phospholipase D autotaxin through cleavage of
the choline group from lysophosphatidyl choline (LPC) species [7].
Recently, LPA 18:1, the OLAMs 9-, and 13-HODE as well as the
lipoxygenase product 20-HETE were identified as endogenous
activators of the vanilloid receptor TRPV1 [8,9,10]. Moreover,
the epoxylipid and 12-lipoxygenase metabolite Hepoxilin A3
(HXA
3
) has recently been identified as endogenous activators of
TRPV1 and TRPA1 and inflammatory pain [11]. Additionally,
leukotriene B4 acts as a chemoattractant for invading immune
cells during inflammation [12]. Both activation of sensory TRP-
channels and recruitment of immune cells contribute to peripheral
sensitization and inflammatory hyperalgesia and enhanced pain
perception [13,14,15].
The aim of this study was to investigate the extent to which lipid
mediators are regulated in the skin and in the downstream located
nociceptive systems, the DRGs and the spinal cord, during UVB-
induced inflammation and if their production and regulation can
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e81228
explain the weak analgesic effects of cyclooxygenase inhibitors
during UVB-induced skin inflammation [16,17,18,19]. Therefore,
the levels of prostanoids, leukotrienes, hydroxyeicosatetraenoic
acids (HETEs), expoxylipids, HODEs and lysophophatidic acids
were determined during peripheral UVB-induced inflammatory
hyperalgesia at the time with the strongest nociceptive response.
The well described model of UVB induced skin inflammation
[20,21,22] is thought to have a high translational potential [22].
Moreover, since the number of genes for CYP enzymes differ
strongly between mice on one side and rats and humans on the
other side [23] we put a special focus on the comparison of levels
of CYP-derived lipids.
Materials and Methods
Ethics Statement
All animal experiments were performed according to the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
approved by the local Ethics Committees for Animal Research
(Darmstadt) with the permit number F95/42. The radiation
procedure was performed under ketamine/xylazin anesthesia, and
all efforts were made to minimize suffering.
Animals and UVB-irradiation
For the irradiation procedure, male C57BL/6 N mice or male
Sprague Dawley rats were purchased from Janvier (Le Geneset-
Saint-Isle, FR) at an age of 6–8 weeks (mice) or 250–300 g (rats)
and anesthesized by intraperitoneal injection of a mixture,
containing ketamine (100 mg?kg
21
) and xylazin (10 mg?kg
21
).
Hair was removed by shaving (AeskulapHIsis GT420) and
additional treatment with a commercial available hair removal
creme (PilcaH) for five minutes. The radiation setup and
calibration device as well as the irradiation procedure were the
same as described by Bishop et al., [16] except using doses of both
1000 mJ/cm
2
and of 1500 mJ/cm
2
for the irradiation of mice and
1000 mJ/cm
2
for Sprague Dawley rats. During the procedure the
eyes of the animals were kept moist using an ointment
(Bepanthen). Shaving and hair removal were also performed in
non-irradiated control animals.
Behavioral Testing
To assess mechanical allodynia, mice were put in test cages on
an elevated grid at least 1 h prior to the measurement to allow
accommodation. Mechanical thresholds of the hind paws were
measured using a Dynamic Plantar Aesthesiometer (Ugo Basile,
Comerio, IT). A steel rod is pushed against the plantar side of the
hindpaw with linear ascending force (0–5 g over 10 s, in 0.5 g/s
intervals) until a fast withdrawal response was observed. Paw
withdrawal latencies were determined in seconds and calculated to
units of Newton (5 g = 0.049 N) and the irradiated and untreated
paws were measured alternately in intervals of 5 minutes.
Determination of Lipids from Tissue Samples by LC-MS/
MS
After dissection, tissue samples were weighted. The weight
ranged from 1 mg (L4–L6-DRGs) to 16 mg (skin) for murine
tissue and from 3 mg (L4–L6-DRGs) to 105 mg (skin) for rat
tissue. Ipsilateral DRGs of the sections L4–L6 out of one animal
were pooled. The procedure was repeated for contralateral L4–
L6-DRGs. Prior to the lipid extraction, tissue samples were
homogenized with 5 zirconium oxide grinding balls for 3 min at
30 s
21
(MM400, Retsch, Haan, Germany).
Lipid extraction and standards. Stock solutions with
2500 ng/ml of the analytes: 5,6 EET, 8,9 EET, 11,12 EET,
14,15 EET, LTB
4
, 5-S-HETE, 12-S-HETE and 15-S-HETE and
the internal standards: 5,6 EET-d11, 8,9 EET-d11, 11,12 EET-d8,
14,15 EET-d8, LTB
4
-d4, 5-S-HETE-d4, 12-S-HETE-d4 and 15-
S-HETE-d4 were prepared in methanol. Working standards were
obtained by further dilution with a concentration range of 0.1–
250 ng/ml for all analytes. For LPAs, Stock solutions with
100,000 ng/ml of all analytes (LPA 16:0, LPA 18:0, LPA 18:1,
LPA 18:2, LPA 18:3 and LPA 20:4) and the internal standard
(LPA 17:0) were prepared in methanol. Working standards were
obtained by further dilution with a concentration range of 0.5–
2500 ng/ml for all the analytes. For prostanoids, Stock solutions
with 50,000 ng/ml of all analytes (PGE
2
, PGD
2
, 6-keto-PGF
1a
,
TXB
2
and PGF
2a
) and the internal standards (PGE
2
-d4, PGD
2
-
d4, 6-keto-PGF
1a
-d4, TXB
2
-d4 and PGF
2a
-d4) were prepared in
methanol. Working standards were obtained by further dilution
with a concentration range of 0.1–1,250 ng/ml for PGE
2
, PGD
2
,
6-keto-PGF
1a
and TXB
2
and 0.4–5,000 ng/ml for PGF
2a
.
Sample pretreatment was performed using liquid–liquid extrac-
tion. Therefore, homogenated tissue was extracted twice with
600 ml of ethyl acetate (EETs, leukotrienes and prostanoids) or
500 ml of 1-butanol saturated with water (LPAs). The combined
organic phases were removed at a temperature of 45uC under a
gentle stream of nitrogen. The residues were reconstituted with
50 ml of methanol/water/butylated hydroxytoluene (BHT)
(50:50:10
23
, v/v/v) (EETs and leukotrienes), 50 ml of methanol
(LPAs) or 50 ml of acetonitrile/water/formic acid (20:80:0.0025,
v/v/v) (prostanoids) and then centrifuged for 2 min at 10,000 g,
and transferred to glass vials waiting for analysis.
Instrumentation for lipid measurement. The LC-MS/
MS system consisted of a QTrap 5500 (AB Sciex, Darmstadt,
Germany) equipped with a Turbo-V source operating in negative
electrospray ionization mode, an Agilent 1200 binary HPLC
pump and degasser (Agilent, Waldbronn, Germany), and an HTC
Pal autosampler (CTC analytics, Zwingen, Switzerland). High-
purity nitrogen for the mass spectrometer was produced by a
NGM 22-LC-MS nitrogen generator (cmc Instruments, Eschborn,
Germany).
For the chromatographic separation of EETs and leukotrienes,
a Gemini NX C18 column and precolumn were used (15062mm
inner diameter, 5 mm particle size, and 110 A
˚pore size;
Phenomenex, Aschaffenburg, Germany). A linear gradient was
used at a flow rate of 0.5 ml/min with a total run time of
17.5 min. Mobile phase A consist of water:ammonia (100:0.05, v/
v), and mobile phase B of acetonitrile:ammonia (100:0.05, v/v).
The gradient changed from 85% A to 10% within 12 min. These
conditions were held for 1 min. Then, the mobile phase shifted
back to 85% A within 0.5 min and it was maintained for 4 min to
reequilibrate the column.
The chromatographic separation of LPAs was achieved using a
Luna C18 column (2062 mm inner diameter, 3 mm) and a
precolumn of same material, (Phenomenex, Aschaffenburg,
Germany) and a linear gradient at a flow rate of 0.4 ml/min
were used. Total chromatographic time was 7 min. Mobile phase
A consisted of 50 mM ammonium acetate/formic acid (100:0.2,
v/v), and mobile phase B of acetonitrile/formic acid (100:0.2, v/
v). The gradient started with 60% A changing to 5% within 1 min
and maintained for 2.5 min. Within 0.5 min, the mobile phase
shifted back to 60% A and was held for 3 min to re-equilibrate the
column.
For the chromatographic separation of prostanoids, a Synergi
4 u Hydro-RP column (15062 mm inner diameter, 4 mm,
Phenomenex, Aschaffenburg, Germany) and a precolumn of same
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e81228
material were used. Chromatographic separation was carried out
in gradient elution mode at a flow rate of 0.3 ml/min. Total run
time was 16 min. Mobile phase A consisted of water/formic acid
(100:0.0025, v/v), and mobile phase B of acetonitrile/formic acid
(100:0.0025, v/v). The linear gradient started with 90% A for
1 min and then changed to 60% A within 1 min. It was held for
1 min at 60% in phase A. Within 1 min, the mobile phase shifted
to 50% in phase A and was held for 2 min. Within 2 min, the
mobile phase shifted to 10% A and was held for 1 min.
Composition of the gradient shifted back to 90% A in one min
and it was maintained for 6 min to re-equilibrate the column.
20 ml (EETs, leukotrienes, and LPAs) or 45 ml (prostanoids) of
the extracted samples were injected into the LC-MS/MS system.
Quantification was performed with Analyst software version 1.5
(Applied Biosystems) using the internal standard method (isotope-
dilution mass spectrometry). Ratios of analyte peak area and
internal standard area (y-axis) were plotted against concentration
(x-axis), and calibration curves were calculated by least-squares
regression with 1/square concentration weighting.
Data Analysis and Statistics
All data are presented as mean 6SEM. To determine
statistically significant differences in all behavioral experiments,
ANOVA for repeated measures was used, followed by Bonferro-
ni’s post hoc correction using GraphPad Prism. For lipid
measurements comparing only two groups, Student’s t-test was
carried out. A confidence interval of 95% and a corresponding p-
value of ,0.05 were considered statistically significant.
Results
To investigate alterations in concentrations of lipid levels during
inflammatory hyperalgesia, we chose a UVB model of skin
inflammation first described for rats by Bishop et al. [16]. First we
tested two irradiation doses for BL/6 mice (1000 mJ/cm
2
and
1500 mJ/cm
2
) because of the stronger pigmentation in mice as
described previously [24]. Mice were irradiated on the plantar site
of the left hind paw, while the right hind paw was not irradiated
and was used as contralateral control. To evaluate mechanical
hyperalgesia in mice, the paw withdrawal latency was monitored
6 h –7 d after irradiation. We observed significantly decreased
mechanical thresholds of the treated mice 24 h after irradiation
with a dose of 1500 mJ/cm
2
but not with the lower dose of
1000 mJ/cm
2
. After three days the mice seemed to recover as the
mechanical thresholds slowly increased and reached baseline level
at day seven post irradiation (Fig. 1). Notably, the strongest and
most stable decrease of mechanical thresholds is within 48 h post
irradiation consistent with behavioral data from rats [16].
Therefore, at this time point skin, L4–L6-DRGs and the
corresponding section of the ipsilateral dorsal horn were dissected
and lipid concentrations were determined by LC-MS/MS. In
mice LPAs, epoxylipids and metabolites, leukotrienes and
prostanoids were measured in skin tissue, L4–L6-DRGs and the
corresponding section of the dorsal horn.
Since COX-metabolites are reliable markers for inflammatory
responses and contribute to peripheral inflammatory hyperalgesia
[1], we first quantified the concentrations of prostaglandin (PG)
D
2
, PGE
2
, PGF
2
aas well as thromboxane B
2
(TXB
2
) and 6-Keto-
PGF
1a
, the stable metabolites of TXA
2
and PGI
2
respectively, in
the tissue samples. Consistent with previous findings from human
skin [25], the concentrations of PGE
2
, were strongly elevated in
murine skin. Moreover the concentrations of TXB
2
and PGF
2
a
were significantly increased at the site of irradiation in skin samples
from irradiated mice (Fig. 2A). Surprisingly, none of the
prostanoids increased in the lumbar DRGs L4–L6 (Fig. 2B) or
in the corresponding dorsal horn sections. In the spinal tissue, 6-
Keto-PGF
1a
levels even decreased in irradiated mice as compared
to untreated mice (Fig. 2C). The concentration changes of
prostanoids in rat tissue were very similar to the murine tissue
(Figure S1).
In the group of LOX-metabolites, LTB
4
, 5-, 12-, 15- and 20-
HETE were measured. Interestingly, the concentrations of two 5-
LOX metabolites LTB
4
and 5-HETE were increased in the skin of
irradiated mice compared with the controls (Fig. 3A). Both, LTB
4
and 5-HETE, are known to be chemoattractant to neutrophils
promoting their migration to the site of inflammation [26,27,28].
In addition, in vitro 5-HETE has been shown to activate directly
TRPV1 [29]. In irradiated rat skin 5- and 15-HETE were
increased compared to the control tissue (Figure S1). In contrast to
the results in the skin, in L4–L6-DRGs of both irradiated mice and
rats only the concentrations of 12-HETE, an endogenous TRPV1
agonist [30], were increased in both tissues (Fig. 3B, Figure S1). In
corresponding sections of the dorsal horn no changes in the levels
of LOX-metabolites could be observed in mice or rats (Fig. 3C,
Figure S1).
Similar to prostanoids and leukotrienes, LPAs with different
chain lengths and saturation states 16:0, 18:0, 18:1, 18:2 were
significantly elevated in the inflamed skin as compared to the
control tissue (Figs. 3D). In contrast, LPA levels were not altered in
lumbar DRGs and the dorsal horn (Figs. 3E, 3F). The oxidized
linoleic metabolites 9- and 13-hydroxyoctadecadienoic acids (9-
and 13-HODE) are endogenous TRPV1-agonists, which are
elevated in heated rat skin [8,31]. Both 9–and 13-HODE were
elevated in the irradiated murine skin (Fig. 3G), while their levels
did not change in the DRGs or spinal dorsal horn tissue as
compared to the untreated mice (Figs. 3H, 3I). Taken together the
data show so far that there is a strong upregulation of the synthesis
of several lipid species in the skin, while there is, with the exception
of 12-HETE, no increased lipid synthesis seen in DRGs or the
spinal cord. These data suggest that lipid signaling is mainly
involved in peripheral responses to UVB irradiation and seems not
to play a major role in potential central mechanisms of UV-B-
induced hyperalgesia.
Next we addressed the question, whether or not the lipids,
which were found to be increased in irradiated skin, can evoke
mechanical allodynia. Since prostanoids, 9- and 13-HODE, as
Figure 1. Mechanical allodynia after UV-B-irradiation in BL/6N-
mice. Mice were irradiated at the plantar side of the hind paw with the
indicated UV-B-doses. Mechanical thresholds were measured up to
seven days post irradiation with the dynamic plantar test; bl: baseline.
Data represents the average 6SEM from 10 animals per group;
**p,0.01, ***p,0.001, two way repeated-measures ANOVA with
Bonferroni post-hoc test.
doi:10.1371/journal.pone.0081228.g001
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 3 December 2013 | Volume 8 | Issue 12 | e81228
well as LPA 18:1 have already been shown to cause mechanical
allodynia upon intraplantar injection in mice [1,8,9], we injected
LTB
4
, 5-HETE (both 10 mlofa6mM solution), LPA 16:0 and
LPA 18:0 (both 10 mlofa10mM solution) in hind paws of mice
and determined mechanical thresholds. Indeed, injection of LTB4
and 5-HETE caused a significant reduction of mechanical
thresholds for 5–6 hours (Figs. 4A, 4B). Moreover, LPA 18:0 but
not LPA 16:0 caused significant and long lasting reduction of
Figure 2. Prostanoid concentrations in skin, DRG and spinal dorsal horn samples from irradiated mice 48 h post irradiation.
Concentrations of prostanoids from isolated skin (A), L4–L6-DRGs (B) and spinal dorsal horn tissue (C) of mice comparing untreated (black bars) versus
irradiated skin (grey bars); 6-k-PGF1a: 6-keto-Prostaglandin F1a. Data represent mean 6SEM from six mice per group; *p,0.05, **p,0.01,
***p,0.001, student’s t-test.
doi:10.1371/journal.pone.0081228.g002
Figure 3. Concentrations of HETEs, LPAs and HODEs in skin, L4–L6-DRGs and spinal dorsal horn samples from irradiated mice.
Shown are the concentrations of LTB
4
, 5-, 12-, 15- and 20-HETE from isolated skin (A), L4–L6-DRGs (B) and the corresponding section of the dorsal
horn (C)., n.d, not detectable. (D–F) Levels of LPAs 16:0, 18:0, 18:1 and 18:2 in skin (D), L4–L6-DRGs (E) and the spinal dorsal horn (F) of irradiated
versus untreated mice. (G–I) Shown are the concentrations of 9- and 13-HODE from skin (G), L4–L6-DRGs (H) and the dorsal horn of the spinal cord (I).
Data represent mean 6SEM from six mice per group, *p,0.05, **p,0.01, student’s t-test.
doi:10.1371/journal.pone.0081228.g003
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e81228
mechanical thresholds four to 24 hours after intraplantar injection
in mice (Figs. 4C). Thus, with the exception of LPA 16:0, all lipids,
which are upregulated in the skin after UVB irridation, are able to
induce mechanical allodynia in mice. These data strongly suggest
that the nociceptive response to UV-irradiation is based on several
mediators, which origin from different COX-independent meta-
bolic pathways.
The well described model of UVB induced skin inflammation
[20,21,22] is thought to have a high translational potential [22].
However, since the number of genes for CYP enzymes differ
strongly between mice on one side and rats and humans on the
other side [23], we put a special focus on the comparison of levels
of CYP-derived lipids. To compare lipid alterations in mice and
rats, we irradiated rats as previously described with a UVB-dose of
1000 mJ/cm
2
[16]. Both arachidonic acid and linoleic acid can be
converted to epoxy-lipids by CYP-epoxygenases [32,33,34].
Members of the epoxyeicosatrienoic acids (EETs), epoxy-metab-
olites of arachidonic acid, are endogenous modulators of the
transient receptor potential (TRP) ion channels TRPV4 and
TRPA1 [35,36]. Moreover, DiHOMEs, hydroxy-metabolites of
linoleic acid, formerly called ‘‘leukotoxin-diols’’ have been shown
to be produced in inflammatory leukocytes and display cytotoxic
effects by causing respiratory burst [37,38]. We determined the
concentrations of EpOMEs (epoxy-metabolites of linoleic acid)
and their dihydro-metabolites DiHOMEs, as well as EETs in skin
samples of both irradiated rats and mice. Among the group of
EETs, only 14,15-EET was detectable in these tissues. In
irradiated murine skin samples all measured lipids from this
group except 14,15-EET were significantly elevated (Fig. 5A).
Similarly, in irradiated rat skin samples the concentrations of all
detectable lipids from this group were significantly increased
(Fig. 5B). In summary, although there is a profound difference in
the number of CYP genes between rats and mice, the synthesis of
lipids metabolized through CYP enzymes in response to UVB
irradiation is very similar in both species.
Discussion
Oxidized metabolites of arachidonic acid and linoleic acid as
well as lysophosphatidic acid (LPA) 18:1 have already been shown
to activate TRP-channels in sensory neurons, leading to enhanced
thermal or mechanical hyperalgesia during inflammation [8,9,30].
Here we combined a UVB-model of local skin inflammation and
an analytical approach to investigate whether or not the
concentrations of prostanoids, leukotrienes, lysophosphatidic acids
and CYP-generated lipids are altered at the site of inflammation,
in the DRGs and in the dorsal horn of the spinal cord.
Interestingly, among all investigated lipid groups, the strongest
concentration increases were observed at the site of inflammation
(Table 1).
PGE
2
is capable of sensitizing primary afferent neurons by
binding one of its four G-protein coupled receptors (EP1-EP4)
leading to TRPV1-sensitization through the PLC-PKC pathway
(EP1) or the cAMP-PKA-pathway (EP2 and EP4) and contributing
to thermal and mechanical hyperalgesia [39,40]. In the group of
measured prostanoids, both PGE
2
and TXB
2
were found to be
elevated in irradiated skin tissue of mice, showing that cycloox-
ygenase-2 and the terminal PGE-synthases and TXA-synthase are
upregulated during peripheral inflammation. Additionally, PGF2a
was found to be elevated after irradiation, indicating that PGI-
synthase is specifically activated in mice during peripheral UVB-
induced skin inflammation. Moreover, the concentrations of LPA
18:1, 9-HODE were significantly elevated in the inflamed skin
tissue of mice. These lipids have been reported to be either direct
or indirect activators of TRPV1 [8,9] and may thus contribute to
thermal hyperalgesia and mechanical allodynia during UVB-
Figure 4. Mechanical thresholds of C57/Bl6 mice after injection
of LTB4, 5-HETE, LPA 16:0 or LPA 18:0. Shown are paw withdrawal
thresholds of wild type BL6 mice after intraplantar injection of LTB
4
(10 mlofa6mM solution, A), 5-HETE (10 mlofa6mM solution B), LPA
16:0 and LPA 18:0 (both 10 mlofa10mM solution, C) and the
corresponding vehicle (0.4% Ethanol (v/v) for LTB
4
and 5-HETE, 1%
DMSO (v/v) for LPA 16:0 and LPA 18:0). Mechanical thresholds were
monitored until 6 h post injection (LTB4 and 5-HETE) or until 30 h post
injection (LPA 16:0 and LPA 18:0). Data represent mean 6SEM from 6–
8 mice per group (LTB
4
and 5-HETE) or 7–11 mice per group (LPA 16:0
and LPA 18:0); *p,0.05, **p,0.01, ***p,0.001 two way repeated-
measures ANOVA with Bonferroni post-hoc test. Structures were
obtained from lipidmaps.org.
doi:10.1371/journal.pone.0081228.g004
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e81228
induced inflammation. Fittingly, 9-HODE has been shown to be
generated in heated skin and recently HODEs were shown to be
markedly upregulated in murine skin biopsies in a post-burn pain
model of partial-thickness Injury [8,41].
Moreover, we show that LTB4, 5-HETE, LPA 16:0 and LPA
18:0 increased in inflamed skin tissue. LTB
4
, and 5-HETE caused
a significant reduction of the mechanical thresholds lasting up to
six hours post injection. Additionally, injection of LPA 18:0 but
not LPA 16:0 resulted in long lasting decreased mechanical
thresholds four to 24 hours after injection, indicating an indirect
and possibly secondary sensitizing function for LPA 18:0 in
peripheral inflammatory hyperalgesia. Several explanations for the
pronociceptive effects of the 5-LO products 5S-HETE and LTB4
have been described that may explain their effects on pain
thresholds. For example, LTB4 receptors which are expressed on
peripheral sensory neurons are thought to be involved in the
sensitization of nociceptors [42], while 5S-HETE can directly
activate TRPV1 [43]. Also, both lipids are able to activate
cytosolic phospholipase A
2
(PLA
2
) and, therefore, to stimulate the
synthesis of pronociceptive prostaglandins (i.e. PGE
2
) [44]. Finally,
LTB4 and 5S-HETE have a strong chemoattractive potential
causing neutrophil recruitment [27,28] or monocyte migration
[45].
These results may explain, why COX-inhibitors administered
even at high doses have relatively weak antinociceptive effects in
reversing thermal hyperalgesia or mechanical allodynia in
irradiated rats [16,17,18,19]. The upregulation of COX-indepen-
dent TRPV1 agonists LPA 18:1, 9-HODE and 5-HETE and
other proalgesic acting lipids, such as LTB
4
and LPA 18:0 may still
cause activation and/or sensitization of TRPV1 and subsequently
thermal hyperalgesia and mechanical allodynia even if prostanoid
synthesis is inhibited. According to these results, a selective
TRPV1-antagonist may be more effective for treating UVB-
induced inflammatory pain than cyclooxygenase inhibitors.
Epoxylipids are generated by CYP-epoxygenases of the
subfamilies 2C and 2J [34]. Interestingly almost all measured
epoxylipids and metabolites were found to be elevated in
irradiated skin of both rats and mice, leading to the conclusion
that upregulation of CYP epoxygenases 2C and 2J and possibly of
phospholipase A
2
, delivering arachidonic acid and linoleic acid as
substrate, occurs in both species during UVB-induced skin
inflammation. Notably, mice and rats are equipped with a
different number and isoform-constellation of CYP-epoxygenases
[23]. However, given the concentration differences of epoxylipids
in irradiated skin of both species, these different isoforms do not
differ in generation or preference of epoxylipids between the two
investigated species, and seem to be regulated similarly during
peripheral inflammation. This is consistent with previous findings
investigating the synthesis and regulation of epoxylipids in rats and
mice under pathophysiological conditions in the cardiovascular
context [46]. Ruparel et al. showed upregulation of CYP2J4 in
trigeminal ganglia (TGs) of rats during CFA-induced inflamma-
tory pain, and showed CYP2J4 expression in TG-neurons, thus
pointing toward a role of CYPs and CYP-derived lipids in
inflammatory pain [47]. We also found CYP-lipids in increased
concentrations during UVB-induced inflammatory pain, however
not in DRGs, but in the dorsal horn and most predominantly in
the skin. These different regulatory locations of CYP-epoxygenases
may be due to differences of the inflammatory models. It is still
unclear which cells produce CYP-derived lipids in the skin, but it is
Figure 5. Comparison of epoxylipid-levels in skin tissue from irradiated mice and rats. Shown are the concentrations of 9,10- and 12,13-
EpOME, and their metabolites 9,10–12,13-DiHOME, as well as 14,15-EET in skin from irradiated mice (A) and rats (B). Data represent mean 6SEM from
five rats and six mice per group; *p,0.05, **p,0.01, ***p,0.001, student’s t-test.
doi:10.1371/journal.pone.0081228.g005
Table 1. Overview of lipid synthesis during UVB-induced inflammatory pain in skin, DRG and dorsal horn tissue from C57Bl6/N
mice and Sprague Dawley rats.
skin DRGs dorsal horn
Prost HETE LPA CYP HODE Prost HETE LPAs CYP HODE Prost HETE LPAs CYP HODE
mouse qqqqq,q12-
HETE
,,,,,,q14,15-
EET
,
rat qqqqq,q12-
HETE
,,, qPGD
2
,, , ,
The tissue was dissected from six mice and six rats per group 48 hours post irradiation (1500 mJ/cm
2
for mice and 1000 mJ/cm
2
for rats) and lipids were extracted and
quantified with LC-MS/MS. Prost: prostanoides, arrow indicates upregulation;
,indicates no significant difference.
doi:10.1371/journal.pone.0081228.t001
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e81228
possible that they are released by resident immune cells as part of
oxidative stress response during UVB-induced skin inflammation.
Recently, TRPV4 expressed in keratinocytes has been exposed
to be involved in generating UV-dependent inflammatory
hyperalgesia. However, the involvement of endogenous TRPV4
modulators has not been investigated [48]. Perhaps synthesis of
oxidized lipids as endogenous TRPV4 activators and the
subsequent neuronal and immune cell responses is a necessary
regulatory step in generating UVB-dependent inflammatory pain.
It is unclear why the observed concentration changes are most
exclusively located in the periphery and at the site of inflamma-
tion. These findings are consistent with the observation that
hyperalgesia following UVB is thought to principally be mediated
by peripheral sensitization [20].
One may speculate that the area of skin inflammation is small
and that only a part of the nociceptors in the skin are activated,
leading to comparably low nociceptive input to the dorsal horn as
compared to an invasive model of inflammation such as
carrageenan or complete freud’s adjuvant (CFA) This also leads
to minor changes in lipid concentrations in the central nervous
system.
In summary, members of LPAs, Epoxylipids, HODEs, leuko-
trienes and prostaglandins were found to be significantly increased
in skin samples from mice in a UVB-model of peripheral
inflammation. In particular, we found already known endogenous
TRPV1-agonists, such as HODEs, LPA 18:1, 5- and 12-HETE to
be increased in irradiated skin. Moreover, LPA 18:0, a lipid that
was not formerly related to inflammatory pain, was found in
increased concentrations in irradiated skin and caused long lasting
mechanical allodynia in mice when injected intraplantarly. The
high abundance of these proalgesic COX-independently generat-
ed lipids may explain, why COX-inhibitors such as ibuprofen only
show weak antinociceptive effects in UVB-induced mechanical
allodynia in rodents [16,17,18,19] and indicate that TRPV1-
antagonists may be more promising in treating UVB-induced
inflammatory pain.
Supporting Information
Figure S1 Prostanoid- and HETE-levels in skin, DRG
and spinal dosal horn tissue from irradiated SD-rats.
Concentrations of prostanoids from isolated skin (A) L4–L6-DRGs
(B) and the corresponding section of the spinal dorsal horn (C)
from irradiated (1000 mJ/cm
2
, grey bars) versus untreated rats
(black bars). (D–F) Levels of HETEs in skin (D), DRG (E) and
dorsal horn tissue (F) from rats. Data represent mean 6SEM from
five rats per group; *p,0.05, **p,0.01, student’s t-test, n.d, not
detectable.
(TIF)
Author Contributions
Conceived and designed the experiments: KS GG AAM JD DB SM.
Performed the experiments: MS JS CDS. Analyzed the data: MS CA NF
YS JS CDS. Wrote the paper: MS KS.
References
1. Petho G, Reeh PW (2012) Sensory and signaling mechanisms of bradykinin,
eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors.
Physiological reviews 92: 1699–1775.
2. Aley KO, McCarter G, Levine JD (1998) Nitric oxide signaling in pain and
nociceptor sensitization in the rat. The Journal of neuroscience: the official
journal of the Society for Neuroscience 18: 7008–7014.
3. Liu M, Huang WL, Wu DS, Priestley JV (2006) TRPV1, but not P2X(3),
requires cholesterol for its function and membrane expression in rat nociceptors.
European Journal of Neuroscience 24: 1–6.
4. AleyKO,MessingRO,Mochly-RosenD,LevineJD(2000)Chronic
hypersensitivity for inflammatory nociceptor sensitization mediated by the
epsilon isozyme of protein kinase C. The Journal of neuroscience: the official
journal of the Society for Neuroscience 20: 4680–4685.
5. Patapoutian A, Tate S, Woolf CJ (2009) Transient receptor potential channels:
targeting pain at the source. Nat Rev Drug Discov 8: 55–68.
6. Wang S, Dai Y, Fukuoka T, Yamanaka H, Kobayashi K, et al. (2008)
Phospholipase C and protein kinase A mediate bradykinin sensitization of
TRPA1: a molecular mechanism of inflammatory pain. Brain 131: 1241–1251.
7. Blaho VA, Hla T (2011) Regulation of mammalian physiology, development,
and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.
Chemical reviews 111: 6299–6320.
8. Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, et al.
(2010) Heat generates oxidized linoleic acid metabolites that activate TRPV1
and produce pain in rodents. J Clin Invest 120: 1617–1626.
9. Nieto-Posadas A, Picazo-Juarez G, Llorente I, Jara-Oseguera A, Morales-Lazaro
S, et al. (2011) Lysophosphatidic acid directly activates TRPV1 through a C-
terminal binding site. Nature chemical biology.
10. Wen H, Ostman J, Bubb KJ, Panayiotou C, Priestley JV, et al. (2012) 20-
hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of TRPV1. The
Journal of biological chemistry.
11. Gregus AM, Doolen S, Dumlao DS, Buczynski MW, Takasusuki T, et al. (2012)
Spinal 12-lipoxygenas e-derived hepoxilin A3 contributes t o inflammatory
hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proceedings of
the National Academy of Sciences of the United States of America.
12. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T (1997) A G-protein-
coupled receptor for leukotriene B-4 that mediates chemotaxis. Nature 387:
620–624.
13. Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, et al. (2009) Peripheral
mechanisms of pain and analgesia. Brain research reviews 60: 90–113.
14. Levine JD, Alessandri-Haber N (2007) TRP channels: targets for the relief of
pain. Biochim Biophys Acta 1772: 989–1003.
15. Schaible HG, Ebersberger A, Natura G (2011) Update on peripheral
mechanisms of pain: beyond prostaglandins and cytokines. Arthritis research
& therapy 13: 210.
16. Bishop T, Hewson DW, Yip PK, Fahey MS, Dawbarn D, et al. (2007)
Characterisation of ultraviolet-B-induced inflammation as a model of hyperal-
gesia in the rat. Pain 131: 70–82.
17. Subramanian N, Ghosal SK, Moulik SP (2005) Enhanced in vitro percutaneous
absorption and in vivo anti-inflammatory effect of a selective cyclooxyg enase
inhibitor using microemulsion. Drug Development and Industrial Pharmacy 31:
405–416.
18. Han A, Maibach HI (2004) Management of acute sunburn. American journal of
clinical dermatology 5: 39–47.
19. Driscoll MS, Wagner RF, Jr. (2000) Clinical management of the acute sunburn
reaction. Cutis; cutaneous medicine for the practitioner 66: 53–58.
20. Bishop T, Ballard A, Holmes H, Young AR, McMahon SB (2009) Ultraviolet-B
induced inflammation of human skin: characterisation and comparison with
traditional models of hyperalgesia. European journal of pain 13: 524–532.
21. Bishop T, Marchand F, Young AR, Lewin GR, McMahon SB (2010)
Ultraviolet-B-induced mechanical hyperalgesia: A role for peripheral sensitisa-
tion. Pain 150: 141–152.
22. Dawes JM, Calvo M, Perkins JR, Paterson KJ, Kiesewetter H, et al. (2011)
CXCL5 mediates UVB irradiation-induced pain. Science translational medicine
3: 90ra60.
23. Martignoni M, Groothuis GMM, de Kanter R (2006) Species differences
between mouse, rat, dog, monkey and human CYP-mediated drug metabolism,
inhibition and induction. Expert Opinion on Drug Metabolism & Toxicology 2:
875–894.
24. Zhang Q, Sitzman LA, Al-Hassani M, Cai S, Pollok KE, et al. (2009)
Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia.
The Journal of investigative dermatology 129: 167–174.
25. Storey A, Rogers JS, McArdle F, Jackson MJ, Rhodes LE (2007) Conjugated
linoleic acids modulate UVR-induced IL-8 and PGE2 in human skin cells:
potential of CLA isomers in nutritional photoprotection. Carcinogenesis 28:
1329–1333.
26. Palmblad J, Malmsten CL, Uden AM, Radmark O, Engstedt L, et al. (1981)
Leukotriene-B4 Is a Potent and Stereospecific Stimulator of Neutrophi l
Chemotaxis and Adherence. Blood 58: 658–661.
27. Canetti C, Silva JS, Ferreira SH, Cunha FQ (2001) Tumour necrosis factor-
alpha and leukotriene B(4) mediate the neutrophil migration in immune
inflammation. British journal of pharmacology 134: 1619–1628.
28. Goetzl EJ (1980) A role for endogenous mono-hydroxy-eicosatetraenoic acids
(HETEs) in the regulation of human neutrophil migration. Immunology 40:
709–719.
29. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, et al. (2000) Direct activation of
capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like
substances. Proc Natl Acad Sci U S A 97: 6155–6160.
30. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, et al. (2000) Direct activation of
capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e81228
substances. Proceedings of the National Academy of Sciences of the United
States of America 97: 6155–6160.
31. Xiao WH, Bennett GJ ( 2012) Effects of mitochondrial poisons on the
neuropathic pain produced by the chemotherapeutic agents, paclitaxel and
oxaliplatin. Pain.
32. Konkel A, Schunck WH (2011) Role of cytochrome P450 enzymes in the
bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta 1814: 210–
222.
33. Spector AA (2009) Arachidonic acid cytochrome P450 epoxygenase pathway.
J Lipid Res 50 Suppl: S52–56.
34. Spector AA, Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular
function. Am J Physiol Cell Physiol 292: C996–1012.
35. Sisignano M, Park CK, Angioni C, Zhang DD, von Hehn C, et al. (2012) 5,6-
EET Is Released upon Neuronal Activity and Induces Mechanical Pain
Hypersensitivity via TRPA1 on Central Afferent Terminals. The Journal of
neuroscience: the official journal of the Society for Neuroscience 32: 6364–6372.
36. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, et al. (2003)
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate
TRPV4 channels. Nature 424: 434–438.
37. Thompson DA, Hammock BD (2007) Dihydroxyoctadecamonoenoate esters
inhibit the neutrophil respiratory burst. Journal of biosciences 32: 279–291.
38. Zheng J, Plopper CG, Lakritz J, Storms DH, Hammock BD (2001) Leukotoxin-
diol: a putative toxic mediator involved in acute respiratory distress syndrome.
Am J Respir Cell Mol Biol 25: 434–438.
39. Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, et al. (2012) microRNA-
21 Regulates Astrocytic Response Following Spinal Cord Injury. The Journal of
neuroscience: the official journal of the Society for Neuroscience 32: 17935–
17947.
40. Masek V, Anzenbacherova E, Machova M, Brabec V, Anzenbacher P (2009)
Interaction of antitumor platinum complexes with human liver microso mal
cytochromes P450. Anti-cancer drugs 20: 305–311.
41. Green D, Ruparel S, Roman L, Henry MA, Hargreaves KM (2013) Role of
Endogenous TRPV1 Agonists in a Post-Burn Pain Model of Partial-Thickness
Injury. Pain.
42. Okubo M, Yamanaka H, Kobayashi K, Fukuoka T, Dai Y, et al. (2010)
Expression of leukotriene receptors in the rat dorsal root ganglion and the effects
on pain behaviors. Molecular pain 6: 57.
43. Gemes G, Koopmeiners A, Rigaud M, Lirk P, Sapunar D, et al. (2012) Failure
of Action Potential Propagation in Sensory Neurons: Mechanisms and Loss of
Afferent Filtering in C-type Units after Painful Nerve Injury. The Journal of
physiology.
44. Wijkander J, O’Flaherty JT, Nixon AB, Wykle RL (1995) 5-Lipoxygenase
products modulate the activity of the 85-kDa phospholipase A2 in human
neutrophils. The Journal of biological chemistry 270: 26543–26549.
45. Migliorisi G, Folkes E, Pawlowski N, Cramer EB (1987) In vitro studies of
human monocyte migration across endothelium in response to leukotriene B4
and f-Met-Leu-Phe. The American journal of pathology 127: 157–167.
46. Brohawn SG, del Marmol J, MacKinnon R (2012) Crystal structure of the
human K2P TRAAK, a lipid- and mechano-sensitive K+ion channel. Science
335: 436–441.
47. Ruparel S, Henry MA, Akopian A, Patil M, Zeldin DC, et al. (2012) Plasticity of
cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during
inflammation. Pain 153: 2031–2039.
48. Moore C, Cevikbas F, Pasolli HA, Chen Y, Kong W, et al. (2013) UVB
radiation generates sunburn pain and affects skin by activating epidermal
TRPV4 ion channels and triggering endothelin-1 signaling. Proceedings of the
National Academy of Sciences of the United States of America.
Lipids in UVB-Induced Inflammatory Pain
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e81228
... Male C57BL/6NRj (8)(9)(10)(11)(12) week) mice were supplied by Janvier, Le Genest, France. All mice were kept in a temperature-(22 ± 0.5 • C), humidity-, (55 %), and light-controlled environment. ...
... The time until paw withdrawal was determined by applying linear ascending force onto the plantar surface at the same rate for each trial (0-5 g over 10 s), with a cutoff time of 20 s as described previously. Baseline measurements were performed on two consecutive days before the treatment phase [12]. ...
Article
Purpose: Diabetes mellitus (DM) is a leading risk factor for corneal neuropathy and dry eye disease (DED). Another common consequence of DM is diabetic peripheral polyneuropathy (DPN). Both complications affect around 50 % of the DM patients but the relationship between DM, DED and DPN remains unclear. Methods: In this study, we examined mice with early onset of DM and PN after streptozotocin (STZ)-induced diabetes (DPN). We compared the early morphological changes of the sciatic nerve, dorsal root and trigeminal ganglia with the changes in the ocular surface, including tear proteomic and we also investigated respective changes in the gene expressions and morphological alterations in the eye tissues involved in tear production. Results: The lacrimal gland, conjunctival goblet cells and cornea showed morphological changes along with alterations in tear proteins without any obvious signs of ocular surface inflammation. The gene expression for respectively altered tear proteins i.e., of Clusterin in cornea, Car6, Adh3a1, and Eef1a1 in eyelids, and Pigr in the lacrimal gland also showed significant changes compared to control mice. In the trigeminal ganglia like in the dorsal root ganglia neuronal cells showed swollen mitochondria and, in the latter, there was a significant increase of NADPH oxidases and MMP9 suggestive of oxidative and neuronal stress. In the dorsal root ganglia and the sciatic nerve, there was an upregulation of a number of pro-inflammatory cytokines and pain-mediating chemokines. Conclusion: The early ocular changes in DM Mice only affect the lacrimal gland. Which, is reflected in the tear film composition of DPN mice. Due to the high protein concentration in tear fluid in humans, proteomic analysis in addition to noninvasive investigation of goblet cells and cornea can serve as a tools for the early diagnosis of DPN, DED in clinical practice. Early treatment could delay or even prevent the ocular complications of DM such as DED and PN.
... and pro-inflammatory (PGE2, PGD2, LTB4, and 12-HETE) compounds, were elevated in keratinocytes exposed to UVB radiation, in accordance with previous research [33,55,56]. On the other hand, the application of the N. oceanica lipid extract after UVB irradiation reduced the levels of prostaglandins PGE2, PGD2, and 15-d-PGJ2. ...
Article
Full-text available
Ultraviolet B (UVB) radiation induces oxidative stress in skin cells, generating reactive oxygen species (ROS) and perturbing enzyme-mediated metabolism. This disruption is evidenced with elevated concentrations of metabolites that play important roles in the modulation of redox homeostasis and inflammatory responses. Thus, this research sought to determine the impacts of the lipid extract derived from the Nannochloropsis oceanica microalgae on phospholipid metabolic processes in keratinocytes subjected to UVB exposure. UVB-irradiated keratinocytes were treated with the microalgae extract. Subsequently, analyses were performed on cell lysates to ascertain the levels of phospholipid/free fatty acids (GC-FID), lipid peroxidation byproducts (GC-MS), and endocannabinoids/eicosanoids (LC-MS), as well as to measure the enzymatic activities linked with phospholipid metabolism, receptor expression, and total antioxidant status (spectrophotometric methods). The extract from N. oceanica microalgae, by diminishing the activities of enzymes involved in the synthesis of endocannabinoids and eicosanoids (PLA2/COX1/2/LOX), augmented the concentrations of anti-inflammatory and antioxidant polyunsaturated fatty acids (PUFAs), namely DHA and EPA. These concentrations are typically diminished due to UVB irradiation. As a consequence, there was a marked reduction in the levels of pro-inflammatory arachidonic acid (AA) and associated pro-inflammatory eicosanoids and endocannabinoids, as well as the expression of CB1/TRPV1 receptors. The microalgal extract also mitigated the increase in lipid peroxidation byproducts, specifically MDA in non-irradiated samples and 10-F4t-NeuroP in both control and post-UVB exposure. These findings indicate that the lipid extract derived from N. oceanica, by mitigating the deleterious impacts of UVB radiation on keratinocyte phospholipids, assumed a pivotal role in reinstating intracellular metabolic equilibrium.
... For assessing the mechanical pain threshold, the animals were placed at least one hour before the measurement in the respective test cages to allow habituation. After this habituation phase, the mechanical paw withdrawal threshold was assessed using a Dynamic Plantar Aesthesiometer (Ugo Basile) as described previously [20]. The baseline measurements were performed on two consecutive days before the treatment phase and the mechanical pain thresholds were assessed every second day. ...
Article
Full-text available
Background Chemotherapy-induced neuropathic pain (CIPN) describes a pathological pain state that occurs dose-dependently as a side effect and can limit or even impede an effective cancer therapy. Unfortunately, current treatment possibilities for CIPN are remarkably confined and mostly inadequate as CIPN therapeutics themselves consist of low effectiveness and may induce severe side effects, pointing out CIPN as pathological entity with an emerging need for novel treatment targets. Here, we investigated whether the novel and highly specific FKBP51 inhibitor SAFit2 reduces paclitaxel-induced neuropathic pain. Methods In this study, we used a well-established multiple low-dose paclitaxel model to investigate analgesic and anti-inflammatory properties of SAFit2. For this purpose, the behavior of the mice was recorded over 14 days and the mouse tissue was then analyzed using biochemical methods. Results Here, we show that SAFit2 is capable to reduce paclitaxel-induced mechanical hypersensitivity in mice. In addition, we detected that SAFit2 shifts lipid levels in nervous tissue toward an anti-inflammatory and pro-resolving lipid profile that counteracts peripheral sensitization after paclitaxel treatment. Furthermore, SAFit2 reduced the activation of astrocytes and microglia in the spinal cord as well as the levels of pain-mediating chemokines. Its treatment also increased anti-inflammatory cytokines levels in neuronal tissues, ultimately leading to a resolution of neuroinflammation. Conclusions In summary, SAFit2 shows antihyperalgesic properties as it ameliorates paclitaxel-induced neuropathic pain by reducing peripheral sensitization and resolving neuroinflammation. Therefore, we consider SAFit2 as a potential novel drug candidate for the treatment of paclitaxel-induced neuropathic pain.
... Serum concentrations of n = 43 different lipid markers of different classes (ceramides, lysophosphatidic acids, endocannabinoids, pterins, prostaglandins, dihydroxyeicosatrienoic acids, and HETEs) were available from n = 102 patients with multiple sclerosis and from n = 301 healthy subjects previously published [14]. Concentrations were analyzed by liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) [15,16]. One of the ceramides, C18Cer, was selected for the present calculations. ...
Article
Full-text available
Bayesian inference is ubiquitous in science and widely used in biomedical research such as cell sorting or {\textquotedbl}omics{\textquotedbl} approaches, as well as in machine learning (ML) and artificial neural networks, and {\textquotedbl}big data{\textquotedbl} applications. However, the calculation is not robust in regions of low evidence. In cases where one group has a lower mean but a higher variance than another group, new cases with larger values are implausibly assigned to the group with typically smaller values. An approach for a robust extension of Bayesian inference is proposed that proceeds in two main steps starting from the Bayesian posterior probabilities. First, cases with low evidence are labelled as {\textquotedbl}uncertain{\textquotedbl} class membership. The boundary for low probabilities of class assignment (threshold $\varepsilonup$) is calculated using computed ABC analysis as a data-based technique for item categorization. This leaves a number of cases with uncertain classification (p $\mathrm{<}$ $\varepsilonup$). Second, cases with uncertain class membership are relabeled based on the distance to neighboring classified cases based on Voronoi cells. The approach is demonstrated on biomedical data typically analyzed with Bayesian statistics, such as flow cytometric data sets or biomarkers used in medical diagnostics, where it increased the class assignment accuracy by 1 -- 10 \% depending on the data set. The proposed extension of Bayesian inference of class membership can be used to obtain robust and plausible class assignments even for data at the extremes of the distribution and/or for which evidence is weak.
... Briefly, a steel rod was pushed against the mid-plantar area of the hind paw with linear ascending force up to 5 g over 10 s and a holding force of 5 g until a withdrawal response occurred. For behavioral experiments a cut-off time of 20 s was set [49]. ...
Article
Full-text available
Background Neuropathic pain is experienced worldwide by patients suffering from nerve injuries, infectious or metabolic diseases or chemotherapy. However, the treatment options are still limited because of low efficacy and sometimes severe side effects. Recently, the deficiency of FKBP51 was shown to relieve chronic pain, revealing FKBP51 as a potential therapeutic target. However, a specific and potent FKBP51 inhibitor was not available until recently which hampered targeting of FKBP51. Methods In this study, we used the well-established and robust spared nerve injury model to analyze the effect of SAFit2 on nerve injury-induced neuropathic pain and to elucidate its pharmacodynamics profile. Therefore, the mice were treated with 10 mg/kg SAFit2 after surgery, the mice behavior was assessed over 21 days and biochemical analysis were performed after 14 and 21 days. Furthermore, the impact of SAFit2 on sensory neurons and macrophages was investigated in vitro. Results Here, we show that the FKBP51 inhibitor SAFit2 ameliorates nerve injury-induced neuropathic pain in vivo by reducing neuroinflammation. SAFit2 reduces the infiltration of immune cells into neuronal tissue and counteracts the increased NF-κB pathway activation which leads to reduced cytokine and chemokine levels in the DRGs and spinal cord. In addition, SAFit2 desensitizes the pain-relevant TRPV1 channel and subsequently reduces the release of pro-inflammatory neuropeptides from sensory neurons. Conclusions SAFit2 ameliorates neuroinflammation and counteracts enhanced neuronal activity after nerve injury leading to an amelioration of nerve injury-induced neuropathic pain. Based on these findings, SAFit2 constitutes as a novel and promising drug candidate for the treatment of nerve injury-induced neuropathic pain.
... Oxidized metabolites of the arachidonic and linoleic acids increase upon systemic stimulation mice with nerve growth factor, a most important neurotrophic factor involved in pain signaling (41,42). In sterile inflammation, evoked by physical burn as well as UVB-mediated sunburn, derivates of oxidized linoleic acid increase (43,44). Lysophosphatidic acid 18:1 and lysophosphatidyl choline 16:0 and 18:1, additional metabolites deriving from phosphatidylcholine precursors, mediate neuropathic pain (45)(46)(47)(48). ...
Article
Full-text available
Within the lipidome oxidized phospholipids (OxPL) form a class of chemically highly reactive metabolites. OxPL are acutely produced in inflamed tissue and act as endogenous, proalgesic (pain-inducing) metabolites. They excite sensory, nociceptive neurons by activating transient receptor potential ion channels, specifically TRPA1 and TRPV1. Under inflammatory conditions, OxPL-mediated receptor potentials even potentiate the action potential firing rate of nociceptors. Targeting OxPL with D-4F, an apolipoprotein A-I mimetic peptide or antibodies like E06, specifically binding oxidized headgroups of phospholipids, can be used to control acute, inflammatory pain syndromes, at least in rodents. With a focus on proalgesic specificities of OxPL, this article discusses, how targeting defined substances of the epilipidome can contribute to mechanism-based therapies against primary and secondary chronic inflammatory or possibly also neuropathic pain.
... A recent assessment of human heat pain and its enhancement by topical capsaicin application showed by an association analysis of human genetic variants that TRPA1 plays a more important role in this pain-related phenotype than TRPV1 [15]. However, in addition to capsaicin, this study also included local ultraviolet (UV-B) irradiation as a second hypersensitizing procedure that not only seems to have influenced sensitivity to heat pain, which can be explained by the excitation of TRPV4 and TRPV1 [16,17], but also sensitivity to cold pain [18]. Therefore, in the present analysis, the role of several different thermosensitive ion channels in the modulation of thermal pain induced by either hot or cold stimuli was determined by the relative importance of variants in their coding genes, using next-generation sequencing (NGS) and the training of artificial intelligence to assign an individual to the correct thermal pain phenotype [15]. ...
Article
Full-text available
Genetic association studies have shown their usefulness in assessing the role of ion 16 channels in human thermal pain perception. We used machine learning to construct a complex 17 phenotype from pain thresholds to thermal stimuli and associate it with the genetic information 18 derived from the next generation sequencing (NGS) of 15 ion channel genes, which are involved in 19 thermal perception, including ASIC1, ASIC2, ASIC3, ASIC4, TRPA1, TRPC1, TRPM2, TRPM3, 20 TRPM4, TRPM5, TRPM8, TRPV1, TRPV2, TRPV3 and TRPV4. Phenotypic information was complete 21 in 82 subjects and NGS genotypes were available in 67 subjects. A network of artificial neurons, 22 implemented as emergent self-organizing maps, discovered two clusters characterized by high or 23 low pain thresholds for heat and cold pain. A total of 1071 variants were discovered in the 15 ion 24 channel genes. After feature selection, 80 genetic variants were retained for association analysis 25 based on machine learning. The measured performance of machine learning-mediated phenotype 26 assignment based on this genetic information resulted in an area under the receiver operating 27 characteristic curve of 77.2%, justifying a phenotype classification based on the genetic information. 28 A further item categorization finally resulted in 38 genetic variants that contributed most to the 29 phenotype assignment. Most of them (10) belonged to the TRPV3 gene, followed by TRPM3 (6). 30 Therefore, the analysis successfully identified the particular importance of TRPV3 and TRPM3 for 31 an average pain phenotype defined by the sensitivity to moderate thermal stimuli. 32
Article
Full-text available
5-Lipoxygenase (5-LO) is the key enzyme in the formation of pro-inflammatory leukotrienes (LT) which play an important role in a number of inflammatory diseases. Accordingly, 5-LO inhibitors are frequently used to study the role of 5-LO and LT in models of inflammation and cancer. Interestingly, the therapeutic efficacy of these inhibitors is highly variable. Here we show that the frequently used 5-LO inhibitors AA-861, BWA4C, C06, CJ-13,610 and the FDA approved compound zileuton as well as the pan-LO inhibitor nordihydroguaiaretic acid interfere with prostaglandin E2 (PGE2) release into the supernatants of cytokine-stimulated (TNFα/IL-1β) HeLa cervix carcinoma, A549 lung cancer as well as HCA-7 colon carcinoma cells with similar potencies compared to their LT inhibitory activities (IC50 values ranging from 0.1–9.1 µM). In addition, AA-861, BWA4C, CJ-13,610 and zileuton concentration-dependently inhibited bacterial lipopolysaccharide triggered prostaglandin (PG) release into human whole blood. Western Blot analysis revealed that inhibition of expression of enzymes involved in PG synthesis was not part of the underlying mechanism. Also, liberation of arachidonic acid which is the substrate for PG synthesis as well as PGH2 and PGE2 formation were not impaired by the compounds. However, accumulation of intracellular PGE2 was found in the inhibitor treated HeLa cells suggesting inhibition of PG export as major mechanism. Further, experiments showed that the PG exporter ATP-binding cassette transporter multidrug resistance protein 4 (MRP-4) is targeted by the inhibitors and may be involved in the 5-LO inhibitor-mediated PGE2 inhibition. In conclusion, the pharmacological effects of a number of 5-LO inhibitors are compound-specific and involve the potent inhibition of PGE2 export. Results from experimental models on the role of 5-LO in inflammation and pain using 5-LO inhibitors may be misleading and their use as pharmacological tools in experimental models has to be revisited. In addition, 5-LO inhibitors may serve as new scaffolds for the development of potent prostaglandin export inhibitors.
Chapter
Background: Data from biomedical measurements usually include many parameters (variables/features). To reduce efforts of data acquisition or to enhance comprehension, a feature selection method is proposed that combines the ranking of the relative importance of each parameter in random forests classifiers with an item categorization provided by computed ABC analysis. Data: The input data space, comprising an example subset of plasma concentrations of d = 23 different lipid markers of various classes, acquired in Parkinson patients and healthy subjects (n = 100 each). Methods: Random forest classifiers were constructed with various different scenarios of the number of trees and the number of features in each tree. The relative importance of each feature calculated by the classifier was submitted to computed ABC analysis, a categorization technique for skewed distributions to identify the most important feature subset “A,” i.e., a reduced-set containing the important few items. Results: Using different parameters for the algorithms, the classification performance of all reduced-set random forest classifiers was almost as good as that of a random forest classifier using the full set of d = 23 lipid markers; all reaching 95% or better classification accuracy. When including additional “nonsense” features consisting of concentration data permutated across the subject groups, these features were never found in the ABC set “A.” The obtained features sets provided better classifiers than those obtained using classical regression methods. Conclusions: Random forests plus computed ABC analysis provided a feature selection without the necessity to predefine the number of features. A substantial reduction of the number of features, following the “80/20 rule,” was obtained. The classifiers using the A-class performed better than with a regression-based feature selection and were (nearly) as good as using the complete feature set. The obtained small feature sets are also well suited for domain experts’ interpretation.
Article
Full-text available
Leukotoxin is clinically associated with acute respiratory distress syndrome (ARDS). Recently, we found that leukotoxin-diol, the hydrated product of leukotoxin, is more toxic than the parent leukotoxin in vitro (Moghaddam and colleagues, Nature Med. 1997;3:562–566). To test if this difference in the toxicity of leukotoxin and leukotoxin-diol exists in vivo, Swiss Webster mice were administered leukotoxin or leukotoxin-diol. All mice treated with leukotoxin-diol died of ARDS-like respiratory distress, whereas the animals exposed to leukotoxin at the same dose survived. Histopathologic evaluation of the lungs revealed massive alveolar edema and hemorrhage with interstitial edema around blood vessels in the lungs of mice treated with leukotoxin-diol, whereas the lungs of mice treated with identical doses of leukotoxin had perivascular edema only and little change in alveolar spaces. Immunohistochemistry showed that the soluble epoxide hydrolase responsible for the hydrolysis of leukotoxin to its diol is concentrated in the vascular smooth muscle of small and medium-sized pulmonary vessels. In addition, 4-phenylchalcone oxide, an inhibitor of soluble epoxide hydrolase, was found to decrease the mortality induced by leukotoxin but had no effect on mortality induced by leukotoxin-diol. These studies provide strong in vivo evidence that leukotoxin may act as a protoxicant and that the corresponding diol is a putative toxic mediator involved in the development of ARDS. Leukotoxin is clinically associated with acute respiratory distress syndrome (ARDS). Recently, we found that leukotoxin-diol, the hydrated product of leukotoxin, is more toxic than the parent leukotoxin in vitro (Moghaddam and colleagues, Nature Med. 1997;3:562–566). To test if this difference in the toxicity of leukotoxin and leukotoxin-diol exists in vivo, Swiss Webster mice were administered leukotoxin or leukotoxin-diol. All mice treated with leukotoxin-diol died of ARDS-like respiratory distress, whereas the animals exposed to leukotoxin at the same dose survived. Histopathologic evaluation of the lungs revealed massive alveolar edema and hemorrhage with interstitial edema around blood vessels in the lungs of mice treated with leukotoxin-diol, whereas the lungs of mice treated with identical doses of leukotoxin had perivascular edema only and little change in alveolar spaces. Immunohistochemistry showed that the soluble epoxide hydrolase responsible for the hydrolysis of leukotoxin to its diol is concentrated in the vascular smooth muscle of small and medium-sized pulmonary vessels. In addition, 4-phenylchalcone oxide, an inhibitor of soluble epoxide hydrolase, was found to decrease the mortality induced by leukotoxin but had no effect on mortality induced by leukotoxin-diol. These studies provide strong in vivo evidence that leukotoxin may act as a protoxicant and that the corresponding diol is a putative toxic mediator involved in the development of ARDS.
Article
Full-text available
Significance Skin protects against harmful external cues, one of them UV radiation, which, upon overexposure, causes sunburn as part of the UVB response. Using genetically engineered mice and cultured skin epithelial cells, we have identified the calcium-permeable TRPV4 ion channel in skin epithelial cells as critical for translating the UVB stimulus into intracellular signals and also into signals from epithelial skin cell to sensory nerve cell that innervates the skin, causing pain. These signaling mechanisms underlie sunburn and in particular sunburn-associated pain. Thus, activation of TRPV4 in skin by UVB evokes sunburn pain, highlighting the forefront-signaling role of the skin and TRPV4.
Article
Full-text available
Astrogliosis following spinal cord injury (SCI) involves an early hypertrophic response that serves to repair damaged blood-brain barrier and a subsequent hyperplastic response that results in a dense scar that impedes axon regeneration. The mechanisms regulating these two phases of astrogliosis are beginning to be elucidated. In this study, we found that microRNA-21 (miR-21) increases in a time-dependent manner following SCI in mouse. Astrocytes adjacent to the lesion area express high levels of miR-21 whereas astrocytes in uninjured spinal cord express low levels of miR-21. To study the role of miR-21 in astrocytes after SCI, transgenic mice were generated that conditionally overexpress either the primary miR-21 transcript in astrocytes or a miRNA sponge designed to inhibit miR-21 function. Overexpression of miR-21 in astrocytes attenuated the hypertrophic response to SCI. Conversely, expression of the miR-21 sponge augmented the hypertrophic phenotype, even in chronic stages of SCI recovery when astrocytes have normally become smaller in size with fine processes. Inhibition of miR-21 function in astrocytes also resulted in increased axon density within the lesion site. These findings demonstrate a novel role for miR-21 in regulating astrocytic hypertrophy and glial scar progression after SCI, and suggest miR-21 as a potential therapeutic target for manipulating gliosis and enhancing functional outcome.
Article
Full-text available
Key points The peripheral terminals of sensory neurons encode physical and chemical signals into trains of action potentials (APs) and transmit these trains to the CNS. Although modulation of this process is thought to predominantly reside at synapses, there are also indications that AP trains are incompletely propagated past points at which axons branch. One such site is the T‐junction, where the single sensory neuron axon branches into peripheral and central processes. In recordings from sensory neurons of dorsal root ganglia excised from adult rats, we identified use‐dependent failure of AP propagation between the peripheral and central processes that results in filtering of rapid AP trains, especially in C‐type neurons. Propagation failure was regulated by membrane input resistance and Ca ²⁺ ‐sensitive K ⁺ and Cl ⁻ currents. Following peripheral nerve injury, T‐junction filtering is reduced in C‐type neurons, which may possibly contribute to pain generation. Abstract The T‐junction of sensory neurons in the dorsal root ganglion (DRG) is a potential impediment to action potential (AP) propagation towards the CNS. Using intracellular recordings from rat DRG neuronal somata during stimulation of the dorsal root, we determined that the maximal rate at which all of 20 APs in a train could successfully transit the T‐junction (following frequency) was lowest in C‐type units, followed by A‐type units with inflected descending limbs of the AP, and highest in A‐type units without inflections. In C‐type units, following frequency was slower than the rate at which AP trains could be produced in either dorsal root axonal segments or in the soma alone, indicating that the T‐junction is a site that acts as a low‐pass filter for AP propagation. Following frequency was slower for a train of 20 APs than for two, indicating that a cumulative process leads to propagation failure. Propagation failure was accompanied by diminished somatic membrane input resistance, and was enhanced when Ca ²⁺ ‐sensitive K ⁺ currents were augmented or when Ca ²⁺ ‐sensitive Cl ⁻ currents were blocked. After peripheral nerve injury, following frequencies were increased in axotomized C‐type neurons and decreased in axotomized non‐inflected A‐type neurons. These findings reveal that the T‐junction in sensory neurons is a regulator of afferent impulse traffic. Diminished filtering of AP trains at the T‐junction of C‐type neurons with axotomized peripheral processes could enhance the transmission of activity that is ectopically triggered in a neuroma or the neuronal soma, possibly contributing to pain generation.
Article
Full-text available
Peripheral mediators can contribute to the development and maintenance of inflammatory and neuropathic pain and its concomitants (hyperalgesia and allodynia) via two mechanisms. Activation or excitation by these substances of nociceptive nerve endings or fibers implicates generation of action potentials which then travel to the central nervous system and may induce pain sensation. Sensitization of nociceptors refers to their increased responsiveness to either thermal, mechanical, or chemical stimuli that may be translated to corresponding hyperalgesias. This review aims to give an account of the excitatory and sensitizing actions of inflammatory mediators including bradykinin, prostaglandins, thromboxanes, leukotrienes, platelet-activating factor, and nitric oxide on nociceptive primary afferent neurons. Manifestations, receptor molecules, and intracellular signaling mechanisms of the effects of these mediators are discussed in detail. With regard to signaling, most data reported have been obtained from transfected nonneuronal cells and somata of cultured sensory neurons as these structures are more accessible to direct study of sensory and signal transduction. The peripheral processes of sensory neurons, where painful stimuli actually affect the nociceptors in vivo, show marked differences with respect to biophysics, ultrastructure, and equipment with receptors and ion channels compared with cellular models. Therefore, an effort was made to highlight signaling mechanisms for which supporting data from molecular, cellular, and behavioral models are consistent with findings that reflect properties of peripheral nociceptive nerve endings. Identified molecular elements of these signaling pathways may serve as validated targets for development of novel types of analgesic drugs.
Article
Full-text available
Recently, specific oxidized linoleic acid metabolites (OLAMs) have been identified as transient receptor potential vanilloid 1 (TRPV1) channel agonists that contribute to inflammatory and heat hyperalgesia mechanisms, yet the specific mechanism responsible for OLAM synthesis in sensory neurons is unknown. Here, we use molecular, anatomical, calcium imaging, and perforated patch electrophysiology methods to demonstrate the specific involvement of cytochrome P450 enzymes (CYPs) in the oxidation of linoleic acid leading to neuronal activation and show that this is enhanced under inflammatory conditions. Additional studies evaluated CYP expressions in the native rat trigeminal ganglia (TG) tissue and cultures as well as changes in their expression pattern following the induction of peripheral inflammation. Fourteen of 20 candidate transcripts were detected in native TG, and 7 of these displayed altered expression under cultured conditions. Moreover, complete Freund's adjuvant-induced inflammation of vibrissal pad selectively increased expression of CYP3A23/3A1 and CYP2J4 transcripts in TG. In situ hybridization studies demonstrated broad expression pattern of CYP3A23/3A1 and CYP2J4 within TG neurons. Anatomical studies characterized the expression of CYP3A1 and the CYP2J families within TG sensory neurons, including those with TRPV1, with about half of all TRPV1-positive neurons showing more prominent CYP3A1 and CYP2J expression. Together, these findings show that CYP enzymes play a primary role in mediating linoleic acid-evoked activation of sensory neurons and furthermore, implicate the involvement of specific CYPs as contributing to the formation of OLAMs that act as TRPV1 agonists within this subpopulation of nociceptors.
Article
Full-text available
Epoxyeicosatrienoic acids (EETs) are cytochrome P450-epoxygenase-derived metabolites of arachidonic acid that act as endogenous signaling molecules in multiple biological systems. Here we have investigated the specific contribution of 5,6-EET to transient receptor potential (TRP) channel activation in nociceptor neurons and its consequence for nociceptive processing. We found that, during capsaicin-induced nociception, 5,6-EET levels increased in dorsal root ganglia (DRGs) and the dorsal spinal cord, and 5,6-EET is released from activated sensory neurons in vitro. 5,6-EET potently induced a calcium flux (100 nm) in cultured DRG neurons that was completely abolished when TRPA1 was deleted or inhibited. In spinal cord slices, 5,6-EET dose dependently enhanced the frequency, but not the amplitude, of spontaneous EPSCs (sEPSCs) in lamina II neurons that also responded to mustard oil (allyl isothiocyanate), indicating a presynaptic action. Furthermore, 5,6-EET-induced enhancement of sEPSC frequency was abolished in TRPA1-null mice, suggesting that 5,6-EET presynaptically facilitated spinal cord synaptic transmission by TRPA1. Finally, in vivo intrathecal injection of 5,6-EET caused mechanical allodynia in wild-type but not TRPA1-null mice. We conclude that 5,6-EET is synthesized on the acute activation of nociceptors and can produce mechanical hypersensitivity via TRPA1 at central afferent terminals in the spinal cord.
Article
Full-text available
Peripheral inflammation initiates changes in spinal nociceptive processing leading to hyperalgesia. Previously, we demonstrated that among 102 lipid species detected by LC-MS/MS analysis in rat spinal cord, the most notable increases that occur after intraplantar carrageenan are metabolites of 12-lipoxygenases (12-LOX), particularly hepoxilins (HXA(3) and HXB(3)). Thus, we examined involvement of spinal LOX enzymes in inflammatory hyperalgesia. In the current work, we found that intrathecal (IT) delivery of the LOX inhibitor nordihydroguaiaretic acid prevented the carrageenan-evoked increase in spinal HXB(3) at doses that attenuated the associated hyperalgesia. Furthermore, IT delivery of inhibitors targeting 12-LOX (CDC, Baicalein), but not 5-LOX (Zileuton) dose-dependently attenuated tactile allodynia. Similarly, IT delivery of 12-LOX metabolites of arachidonic acid 12(S)-HpETE, 12(S)-HETE, HXA(3), or HXB(3) evoked profound, persistent tactile allodynia, but 12(S)-HpETE and HXA(3) produced relatively modest, transient heat hyperalgesia. The pronociceptive effect of HXA(3) correlated with enhanced release of Substance P from primary sensory afferents. Importantly, HXA(3) triggered sustained mobilization of calcium in cells stably overexpressing TRPV1 or TRPA1 receptors and in acutely dissociated rodent sensory neurons. Constitutive deletion or antagonists of TRPV1 (AMG9810) or TRPA1 (HC030031) attenuated this action. Furthermore, pretreatment with antihyperalgesic doses of AMG9810 or HC030031 reduced spinal HXA(3)-evoked allodynia. These data indicate that spinal HXA(3) is increased by peripheral inflammation and promotes initiation of facilitated nociceptive processing through direct activation of TRPV1 and TRPA1 at central terminals.
Article
We studied the effects of leukotrienes on in vitro functions of neutrophil polymorphonuclear (PMN) granulocytes. Leukotriene B4 (LTB4) evoked a stimulated and directed migration of neutrophils under agarose with an optimum concentration of 10(-6)M, whereas two nonenzymatically formed isomers (compounds I and II) induced this response at 10(-5)M. Leukotriene C4 (LTC4) and 5-hydroxyeicosate-traenoic acid (5-HETE) did not affect this PMN migration. At the same optimum concentrations, LTB4 and compounds I and II augmented PMN adherence to nylon fibers. The chemotactic and adherence responses were of the same magnitude as with formal-Met-Leu-Phe (fMLP) at 10(-7)M. None of the leukotrienes influenced the spontaneous or phagocytosis-associated chemiluminescence or the ability to kill Staphylococcus aures. The cyclooxygenase inhibitor, indomethacin, inhibited only partly the fMLP-induced migration at high concentrations and stimulated migration at 2.5 x 10(- 7)M, suggesting that arachidonic acid was then mainly metabolized by the lipoxygenase pathways. The lipoxygenase and cyclooxygenase inhibitor, eicosatetraynoic acid, inhibited both spontaneous and stimulated migration at greater or equal to 2.5 x 10(-5)M, but not at lower concentrations. Thus, since LTB4, and to a lesser degree compounds I and II, stimulated migration and adhesion, it is suggested that these mediators could be of importance for the emigration of neutrophils from blood vessels to areas of inflammation.
Article
Oxidized linoleic acid metabolites (OLAMs) are a class of endogenous transient receptor potential vanilloid 1 (TRPV1) channel agonists released upon exposure of tissue to transient noxious temperatures. These lipid compounds also contribute to inflammatory and heat allodynia. As persistent pain after a burn injury represents a significant clinical challenge for treatment, we developed an in vivo rat model of partial thickness cutaneous thermal injury and examined whether TRPV1 and specific OLAM metabolites play a role in mediating post-burn pain injury. This peripheral model of burn injury had marked thermal allodynia peaking at 24 hours post thermal injury, with allodynia being maintained for up to 7 days. Immunohistochemical characterization of tissue taken from injury site revealed an increase of leukocyte/macrophage infiltration that was co-localized with TRPV1-positive fibers. Utilizing this peripheral thermal injury model we found that pharmacological blockade of peripheral TRPV1 receptors reduced thermal allodynia by about 67%. Moreover, there was a significant increase in OLAM levels compared to naïve controls in hindpaw skin biopsies. Additional studies on metabolism of [C(14)]-linoleic acid in skin biopsies revealed the role of the cytochrome P450 (CYP) system in mediating the metabolism of linoleic acid post thermal injury. Finally, we demonstrated direct inhibition of OLAMs using OLAM antibodies and indirect inhibition using the CYP inhibitor ketoconazole significantly reduced post-burn thermal allodynia. Collectively, these findings point to a novel role of the OLAMs and CYP-related enzymes in generating post-burn allodynia via activation of peripheral TRPV1.